Cevdet Samikoglu is the founder of Biosplice Therapeutics. Biosplice Therapeutics has raised $778M in total funding. Latest round: Series E.
Cevdet Samikoglu is the CEO of Biosplice Therapeutics, a biotechnology company focused on advancing an alternative splicing platform for small-molecule therapeutics. He has held the CEO position at Biosplice Therapeutics from March 2021 to the present.
Full founder directory · Investor directory · Company funding database · Fundraising library